The role of hydroxychloroquine in COVID-19: Where do we stand?
Hydroxychloroquine (HCQ) is a drug, which has long been used in the treatment of malaria, rheumatoid arthritis, systemic lupus erythematosus, and Sjogren’s syndrome. Recently with the COVID-19 pandemic hitting the world, there have been studies suggesting that hydroxychloroquine may be useful both i...
Main Authors: | Ranjit Mohan Anjana, Nadiminty Ganapathi Sastry, Muthu Ramuu, Prasanna Kumar Gupta, Jaggi Shalini, Brijendra Kumar Srivastava, Chaithanya Murthy Kocherlakota, Tata Sameer Nandan, Gangadhara Praveen, Jyotish Nair, Routray Philips, Viswanathan Mohan, Ranjit Unnikrishnan |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2020-01-01
|
Series: | Journal of Diabetology |
Subjects: | |
Online Access: | http://www.journalofdiabetology.org/article.asp?issn=2078-7685;year=2020;volume=11;issue=2;spage=65;epage=70;aulast=Anjana |
Similar Items
-
Extreme Interocular Asymmetry in an Atypical Case of a Hydroxychloroquine-Related Retinopathy
by: Gabriel Hallali, et al.
Published: (2022-07-01) -
Short-term insulin therapy at the time of diagnosis of Type 2 diabetes leads to better glycemic control and improved beta cell function
by: Siddharth Madnani, et al.
Published: (2019-01-01) -
The use of Hydroxychloroquine in the Treatment of COVID-19
by: Kamer TECEN-YÜCEL, et al.
Published: (2020-09-01) -
Nanomedicine Reformulation of Chloroquine and Hydroxychloroquine
by: David M. Stevens, et al.
Published: (2020-12-01) -
Drugs affecting HbA1c levels
by: Ranjit Unnikrishnan, et al.
Published: (2012-01-01)